Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs
Khartis Therapeutics Raises $50M Series B Khartis Therapeutics has raised $50 million in Series B funding to advance its oral medicine pipeline.mForge Life Science Partners led the round. Longwood Fund The post Khartis Therapeutics Raises $50M To Advance Oral Immunology Drugs appeared first on Ventureburn .
We haven't written up this one. Ventureburn has the full story — the link below goes straight to it.